Health IT

An Israeli biotech just published a patent for a 'mucoadhesive' gel that makes drugs stick inside the nose. It's a key step in a multi-billion dollar race.

A key update to a revolutionary cancer therapy reduces post-treatment restrictions, signaling a new era of patient-centric care and system efficiency in Canada.

EnableComp is pulling back the curtain on enterprise AI, detailing a production model that boosts development 5-7x while navigating healthcare's tough regulations.

With a history of beating expectations and a flurry of strategic moves, Quest Diagnostics' July 23rd earnings report is a key vital sign for the entire diagnostics sector.

Humana secures a massive Illinois Medicaid contract, expanding its reach statewide. This strategic move signals a major shift towards whole-person care.

A new partnership is bringing enterprise voice AI to the Medicare front lines, promising to ease a system strained by high call volumes and complex rules.

Heart + Paw is ditching one-size-fits-all pet care, betting on vet-guided personalization. Is this tech-driven approach the future of the industry?

With a key regulatory win in the UAE, WAT Medical is set to introduce its drug-free neuromodulation devices to a booming Middle Eastern healthcare market.

A new survey reveals Tennessee seniors delay hearing care for years due to cost fears, risking cognitive decline and falls. But are the solutions already here?

With top rankings from Ad Age and MM+M, Quad proves its integrated model is a force. A deep data stack and a strategic healthcare push are key.

A landmark grant and trial expansion signal a pivotal shift in Parkinson's research, blending genetic targeting, global collaboration, and digital health.

New research reveals that custom 3D braces can actively correct spinal curves, not just prevent them from worsening. This paradigm shift in non-surgical care offers new hope.

New data on ersodetug reveals a calculated strategy to conquer hyperinsulinism, balancing patient hope with the harsh realities of the biotech market.

With $1.25M in new funding, Avricore Health isn't just raising capital; it's accelerating a strategic pivot to the lucrative UK market for its HealthTab platform.

KiWear's new touchless smart ring controller enters a crowded market, betting that universal device control, not just health stats, is the future of wearables.

With record AI investment and grand sustainability claims, Ant Group is building the future. But as it pushes into our health and wallets, who truly benefits?

FiberSense AG’s new 28-day CGM sensor just won European approval, challenging market leaders. But the real growth signal is its plan to move beyond glucose.

Central & Eastern Europe's tech value hits $128B, but a new report shows its true worth is over $170B as its top firms relocate for Western capital.

A new NIH contract for Tryfacta signals more than a business win; it highlights how AI-driven staffing is becoming critical to national healthcare infrastructure.

With 33% growth dwarfing industry norms, NNB Nutrition's integrated model and fermentation tech aren't just winning—they're rewriting the rules for wellness.